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ABSTRACT
Genome engineering using single-stranded oligo-
nucleotides is an efficient method for generating
small chromosomal and episomal modifications in
a variety of host organisms. The efficiency of this
allelic replacement strategy is highly dependent on
avoidance of the endogenous mismatch repair
(MMR) machinery. However, global MMR inactiva-
tion generally results in significant accumulation
of undesired background mutations. Here, we
present a novel strategy using oligos containing
chemically modified bases (20-Fluoro-Uridine,
5-Methyl-deoxyCytidine, 2,6-Diaminopurine or Iso-
deoxyGuanosine) in place of the standard T, C,
A or G to avoid mismatch detection and repair,
which we tested in Escherichia coli. This strategy
increases transient allelic-replacement efficiencies
by up to 20-fold, while maintaining a 100-fold lower
background mutation level. We further show
that the mismatched bases between the full
length oligo and the chromosome are often not
incorporated at the target site, probably due to
nuclease activity at the 50 and 30 termini of the
oligo. These results further elucidate the mechan-
ism of oligo-mediated allelic replacement (OMAR)
and enable improved methodologies for efficient,
large-scale engineering of genomes.
INTRODUCTION
Oligo-mediated genomic modiﬁcation proceeds via trans-
formation of short single-stranded (ss) DNA into cells
expressing ssDNA-annealing recombinase proteins,
which mediate an Okazaki-like allelic-replacement event
at the replication fork (1). These synthetic ssDNA oligos
can be used to insert novel sequences, to produce
mismatches of >30bp, or to delete gene segments (2).
This oligo-mediated allelic-replacement (OMAR) process
is distinctly different from double-stranded (ds) DNA-
based recombination engineering [more commonly
referred to as recombineering (3–5)] in that: (i) only an
easily synthesized short ss-oligonucleotide (50–90bp) is
needed, as opposed to a larger (>700bp) selectable
dsDNA cassette and (ii) the efﬁciency of oligo-based
allelic replacement is up to 30% versus 0.01% for
dsDNA recombineering (6). Furthermore, only a ssDNA
binding protein is needed for OMAR (7,8). In contrast,
dsDNA recombineering needs additional homologous
recombination machinery such as exonucleases. This
high allelic-replacement efﬁciency facilitates Multiplex
Automated Genome Engineering (MAGE), which has
been used to iterate cyclical rounds of allelic replacement
to simultaneously modify many chromosomal targets in a
high-throughput fashion (9,10).
Here, we deﬁne the process of oligo-mediated site-
speciﬁc genomic modiﬁcation as ‘allelic replacement’
based on its putative mechanism of action in Escherichia
coli. It has been observed that oligos designed to target the
lagging strand provide for up to 30-fold greater replace-
ment efﬁciency than compared with leading strand-
targeting oligos (2,11). In the Gram-negative E. coli
bacteria, a single-stranded DNA binding protein derived
from the  -phage, Red-Beta, facilitates the annealing of
the oligo to the homologous chromosomal sequence
by stabilizing the ssDNA secondary structure, and
may also protect against nuclease degradation (12).
The processing and annealing of oligos to an exposed
single-stranded region of the chromosome at the replica-
tion fork may show mechanistic similarities with those of
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a full-length single-stranded intermediate may be also
mediate dsDNA recombineering (13,14). However,
detailed mechanisms of oligo-mediated allelic replacement
still remain to be elucidated.
In addition to prokaryotic systems, the use of short
oligonucleotides to generate site-speciﬁc mutations in the
chromosome has been well-established for eukaryotic
systems including yeast (15,16), mammalian cells (17,18)
and plants (19,20). Strategies using RNA–DNA chimeric
oligonucleotides (RDO) and triplex-forming oligonucleo-
tides (TFO) have been developed (21,22) based on earlier
observation that single-stranded oligodeoxynucleotides
(ODN) could generate site-speciﬁc changes to the yeast
chromosome (23). Chemical modiﬁcations to the ODNs
such as phosphorothioate linkages (24) or base variations
such as locked nucleic acid (LNA) have also been shown
to improve the conversion efﬁciency (25). While reports of
efﬁciencies of up to 9% have been documented (26), the
conversion efﬁciency has generally remained 0.01–0.1%
(21). These limited efﬁciencies are likely linked to DNA
repair and homologous recombination proteins (e.g.
MSH2, RAD51 and RAD54), which have been implicated
in this oligo-mediated conversion process (27,28).
Previous studies showed that the endogenous mismatch
repair (MMR) system in E. coli can signiﬁcantly reduce
the efﬁciency of OMAR by correcting mismatched bases
introduced as a part of the synthetic oligonucleotide (29).
Of the several mismatch repair pathways employed by
E. coli, the methyl-directed MutHLS system speciﬁcally
acts on mismatches, insertions, deletions of 1–6nt
(30,31). Mispaired bases are ﬁrst detected by the MutS
protein dimer at the mismatch site, which triggers MutL
recruitment. Together, MutS and MutL activate the endo-
nuclease MutH, which preferentially nicks the
unmethylated strand of the hemi-methylated dGATC
site of newly synthesized DNA. The excision and repair
synthesis is subsequently carried out by one of several
single-stranded nucleases, DNA polymerase III, ssDNA
binding protein and DNA ligase. Various in vitro and
in vivo studies have suggested that the correction efﬁciency
of this MMR system varies based on the type of
mismatches present (30,32,33). Costantino and Court
(29) showed that the efﬁciency of OMAR could be
increased by more than 100-fold by knocking out mutS.
This approach enabled the detection of recombinants via
low-throughput PCR screening ( 50–100 clones) instead
of traditional antibiotic marker selections (>10
6 colonies).
However, a DmutS strain suffers from a 100-fold higher
background mutation rate, which causes undesired muta-
tions to accumulate (34). Furthermore, mutator strains
tend to have decreased ﬁtness under laboratory conditions
in comparison to wild-type strains, because most random
mutations are deleterious (35,36).
Here, we present a strategy using oligonucleotides con-
taining commercially available chemically modiﬁed base
analogs to avoid recognition and correction by the
native mismatch repair system. We also describe results
suggesting that oligos are processed by nucleases at the
replication fork, causing incomplete incorporation of the
full-length oligo. These results will facilitate the design of
improved oligos for allelic replacement in high-throughput
genomic engineering applications.
MATERIALS AND METHODS
Abbreviations
Table 1 lists the abbreviations used in this article.
Media, chemicals and reagents
Liquid cultures of all strains were grown in LB-min-rich
media containing tryptone (10g/l), yeast extract (5g/l)
and NaCl (5g/l), and buffered to pH 7.45 with NaOH.
Chloramphenicol (cm) and kanamycin (kan) were added
to LB-agar plates (LB-min with 15g/l agar) at con-
centrations of 20mg/ml and 30mg/ml, respectively. X-Gal
(40mg/ml) and IPTG (0.1mM) were used on LB-min
plates for functional assay of b-galactosidase activity.
MacConkey–Maltose (Mac–Mal) or MacConkey–
Galactose (Mac–Gal) agar plates were made by adding
D-(+)-maltose monohydrate (10g/l) or D-(+)-galactose
(10g/l), respectively, to Difco MacConkey Agar Base
(40g/l) which contains peptone (17.0g/l), proteose
peptone (3.0g/l), bile salts no. 3 (1.5g/l), NaCl (5.0g/l),
agar (13.5g/l), neutral red (30mg/l) and crystal violet
(1mg/l). Multiplex PCR kits were purchased from
Qiagen (Cat #206143). PCR primers and oligonucleotides
were synthesized by Integrated DNA Technologies (IDT)
with standard puriﬁcation for 90-bp oligonucleotides and
vendor recommended puriﬁcation for modiﬁed bases.
Sanger DNA sequencing was performed by Agencourt
Bioscience Corporation.
Oligonucleotides
The Oligonucleotides (oligos) used in this study (listed in
full in Table 2) are targeting the lagging strand of
replicating DNA, meaning that they have the complemen-
tary sequence to the lagging strand.
Strains used
Escherichia coli strains EcNR1 and EcNR2 have been pre-
viously described (9). In brief, a defective Phage  -Red
construct was introduced by P1 transduction into E. coli
MG1655 at the bioA location to produce EcNR1
(DbioA::l-Red-bla). The relevant   genes Reda, Redb
Table 1. List of abbreviations used in this article
AR Allelic replacement
PT bases Phosphorothioated bases
F-U 20 Fluoro dU
F-A 20 Fluoro dA
F-G 20 Fluoro dG
F-C 20 Fluoro dC
5-Me-C 5-Methyl dC
DiPr 2,6-Diaminopurine
2-AP 2-Aminopurine
Iso-G Iso-dG
Iso-C Iso-dC
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temperature sensitive cI857 repressor. EcNR2 was made
by using  -Red homologous recombination to replace
mutS with a chloramphenicol acetyltransferase (cat)
cassette in EcNR1, thereby generating the DmutS::cat
genotype. EcZS2 was made by introducing a kanamycin
resistance (kan) cassette to replace the recA gene in
EcNR1, generating a DrecA::kan genotype.
Oligo-mediated allelic replacement
Electrocompetent EcNR1 and EcNR2 cells induced for
allele replacement were generated as previously described
(9). In brief, individual colonies from a freshly streaked
overnight plate were inoculated into 3ml LB-min aliquots
and grown in a rotator drum at 300 r.p.m. at 32 C.
Upon reaching OD600 of 0.7, the glass tubes were moved
to a 42 C shaking water bath for 15min to induce the
expression of  -Red proteins. Cells were then immediately
chilled on ice for at least 5min and subsequently made
electrocompetent by repeated (at least twice) pelleting
and resuspension in cold sterile dH2O. One microliter
of cells ( 7 10
8) were ﬁnally concentrated 20-fold into
50ml reactions containing oligos (typically  1–5mM) in
dH2O and electroporated with a BioRad GenePulser
using a 1mm gap cuvette at 1.8kV, 25mF and 200.
Electroporated reactions were immediately added to 3ml
of warm LB-min media and recovered for at least 3h prior
to plating.
Colorimetric assays to determine allelic-replacement
efﬁciencies
Allelic-replacement efﬁciencies were determined by using
oligos (Table 2) designed to introduce an inactivating
nonsense mutation in the lacZ, malK or galK gene, and
then screening for the function of that gene. All oligos
used were designed to be complementary to the lagging
strand of the replicating chromosome. Inactivating the
lacZ gene abolishes b-galactosidase activity and results
in white colonies on LB-min X-Gal/IPTG agar plates,
rather than the blue colonies indicative of a functional
lacZ gene. Targeted inactivation of the malK gene
abolishes the ability of cells to catabolize maltose and
results in white colonies on the pH-indicated Mac–Mal
agar plates, compared with red colonies from a functional
malK gene. Similarly, inactivation of the galK gene can be
screened on Mac–Gal plates. Cells are generally plated at
a density of 300–500 colonies per plate, after which the
allelic-replacement efﬁciency is calculated from the ratio
of the number of mutants to total cells. In general, cells
were recovered for at least 3h after electroporation to a
density of 10
9 cells/ml prior to plating. The 3h recovery
ensured that all replicating chromosomes [up to 8h in rich
medium (37)] have properly segregated to separate
daughter cells, thereby guaranteeing clonality of each
colony on the plate. Colonies produced from this proced-
ure are always mono-colored, whereas a shorter recovery
time often produced sector-colored colonies suggesting
non-clonality.
RESULTS
In vivo characterization of MutS binding and mismatch
repair efﬁciency
We ﬁrst performed a detailed characterization of the
ability of the E. coli mismatch repair system to correct
different types of mismatches in vivo. We designed 90bp
lagging strand targeting oligos to inactivate either the lacZ
or malK genes by incorporation of a premature nonsense
stop codon, which could be detected by colorimetric assay.
Eight oligos targeting several different locations in lacZ or
malK were designed (lacZm9v1 through 7, malKm1v1),
which generated each of eight possible single base pair
mismatches (C:C, T:T, G:G, A:A, C:T, C:A, G:T, G:A).
Allelic-replacement experiments were performed by
introducing each oligo into the mutS(+) EcNR1 strain
or the mutS( ) EcNR2 derivative. The efﬁciency of
allelic replacement is deﬁned as the number of mutant
cells per total colony forming units (CFU) as determined
by the ratio of either white versus total colonies on LB-X-
Gal/IPTG plates for lacZ-inactivating oligos, or white
versus total colonies on Mac–Mal plates for malK-
inactivating oligos. Consistent with previous observations
(29,30,32), we found that the efﬁciency of mismatch repair
depended on the base pairing type (Figure 1a), with C:C
mismatches very poorly corrected and G:G mismatches
most efﬁciently corrected. Interestingly, we also observed
context dependency of MMR correction, and found an
oligo (lacZm7v1) that generated an A:G (chromo-
some:oligo) mismatch at +25bp position of the lacZ
gene at  20% allelic-replacement efﬁciency for both
mutS(+) and mutS( ) strains. The lacZm7v1 oligo is dif-
ferent from the lacZm9v1 oligo only at the mismatched
base with a G instead of an A, but has a greatly increased
efﬁciency of 20% versus 5% in the mutS(+) strain.
In contrast, the lacZm9v4 oligo, which generated a G:A
mismatch, was only 3.3% efﬁcient in the presence of mutS
and 20.9% efﬁcient in its absence. In general, mismatches
containing the more common transition mutations were
better corrected by MutS than transversion mutations.
We further observed that oligos containing eight or
more mismatches have the same allelic-replacement efﬁ-
ciency in both mutS(+) and mutS( ) strains (Figure 1b),
consistent with previous ﬁndings (6, 31). Thus the ability
of mutS to recognize the mismatch lesion is critical for
MMR activation, in terms of both mismatch type and size.
Mismatch repair evasion using modiﬁed bases
The E. coli MutS protein appears to be evolutionarily
optimized to bind at high afﬁnity to G:T mismatches
and at low afﬁnity to C:C mismatches, which correspond,
respectively, to the most and least frequent polymerization
errors during DNA replication (12). Since MutS binds
poorly to the infrequently occurring C:C mismatches, it
is likely that MutS will have reduced afﬁnity to even more
unusual DNA base pairing. We thus hypothesized that
MutS cannot bind to some mismatches created by base
pairing with non-standard nucleotides due to distortions
of the DNA backbone not found in nature (33). Oligos
containing these modiﬁed mismatching bases should have
7340 Nucleic Acids Research, 2011,Vol.39, No. 16reduced MMR correction and increased allelic-
replacement efﬁciency, especially for otherwise efﬁciently
corrected mismatches (e.g. G:T, G:G). To test this hypoth-
esis, we designed 90-mer oligos with the mismatching base
containing non-standard ribose or nucleobase chemical
modiﬁcations that were commercially available (Table 2)
against the screenable lacZ and malK genes. The internal
modiﬁed bases we explored include: (i) 20 Fluoro bases
(A, G, U, C), which have a ﬂuorine modiﬁed ribose
known to increase base pair binding afﬁnity and confer
some nuclease resistance compared with native RNA (38);
(ii) Phosphorothioated bases, which contain a sulfur atom
in place of a non-bridging oxygen in the phosphate
backbone, which is known to increase resistance to
nuclease degradation (39); (iii) 2-Aminopurine, which is
a naturally ﬂuorescent deoxyAdenosine analog that leads
to reversible inactivation of the E. coli MMR when sup-
plemented in bulk (40); (iv) 2,6-Diaminopurine, which
forms three hydrogen bonds when base paired with
deoxyThymidine, thus increasing binding afﬁnity; (v)
5-Methyl-deoxyCytidine, which has increased binding
afﬁnity; (vi) Iso-deoxyGuanosine, which will base pair
with 5-Methyl Iso-deoxyCytidine but not with
deoxyCytidine (41), and Iso-deoxyCytidine, which will
base pair with Iso-deoxyGuanosine, but not with
deoxyGuanosine; and (vii) deoxyUridine, which can
substitute for deoxyThymidine. Oligos were synthesized
by Integrated DNA Technologies and HPLC- or
PAGE-puriﬁed based on vendor recommendations. For
side-by-side comparison, we also obtained oligos with
standard nucleotides for each of the modiﬁed oligos.
Modiﬁed or unmodiﬁed oligos were introduced into
EcNR1, and the efﬁciency of oligo incorporation was
assessed by colorimetric assay on LB-XGal/IPTG or
Mac-Mal color indicator plates.
We found that oligos with certain modiﬁed bases could
increase the allelic-replacement efﬁciency by more than
10–20-fold in a mutS(+) strain (Figure 2a). In particular,
oligos containing 20-Fluoro-deoxyUridine, 5-Methyl-
deoxyCytidine, 2,6-Diaminopurine or Iso-deoxy
Guanosine had the most improved allelic-replacement
efﬁciencies. Oligos with phosphorothioated bases A, C
and T at the mismatch site had an average of 5-fold im-
provement over non-phosphorothioated oligos. No sig-
niﬁcant improvement in allelic-replacement efﬁciency
was observed for oligos with phosphorothioated-deoxy
Guanosine, 2-Aminopurine, 20-Fluoro-deoxyAdenosine,
20-Fluoro-deoxyGuanosine or deoxyUridine. Using strain
EcNR2, we also quantiﬁed the allelic-replacement efﬁ-
ciency for these modiﬁed oligos in the absence of
mutS. Replacement efﬁciencies were further improved in
this DmutS background (Figure 2b), suggesting that while
certain modiﬁed bases could signiﬁcantly evade mutS de-
tection, some level of mutS activity was still present.
Sequencing of the lacZ and malK genes from the mutant
white colonies conﬁrmed that DNA polymerase correctly
replicated the modiﬁed bases. Oligos with Iso-deoxy
Cytidine and 20 Fluoro-deoxyCytidine did not result in
any allelic replacement, presumably due to signiﬁcant
disruption of DNA polymerization by these bases.
Taken together, our results suggest that the intact MMR
system can be easily side-stepped by careful design of the
oligonucleotide sequence with the help of modiﬁed bases.
We calculated the MMR correction efﬁciency as the
difference in allelic-replacement efﬁciencies between the
mutS( ) and mutS(+) strains normalized to the absolute
mutS( ) allelic-replacement efﬁciency. The MMR correc-
tion efﬁciency was calculated for each mismatch type for
both standard bases and the best performing modiﬁed
bases (Figure 2c). For mismatches naturally well-
recognized by mutS and corrected at near 100% efﬁciency
by MMR (e.g. G:T or T:C), utilization of modiﬁed bases
20-Fluoro-deoxyUridine or 5-Methyl-deoxyCytidine sig-
niﬁcantly decreased the MMR correction efﬁciency to
levels similar to wild-type C:C mismatch correction.
Furthermore, MMR-correction of C:A and G:G
mismatches were more efﬁciently avoided using
2,6-Diaminopurine and Iso-deoxyGuanosine modiﬁed
bases, respectively. Thus, 20-Fluoro-deoxyUridine can be
used as a substitute for deoxyThymidine, 5-Methyl-
deoxyCytidine for deoxyCytidine, 2,6-Diaminopurine
for deoxyAdenosine and Iso-deoxyGuanosine for
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allelic replacement by avoidance of the native MMR ma-
chinery. The use of oligos with modiﬁed bases is especially
attractive for performing allelic replacement in organisms
with less well-described MMR systems or when a general
mutator phenotype, such as that of DmutS, needs to be
avoided to reduce background mutations.
Previous studies have shown that six C–C mismatches
spaced every 3bp in tandem were sufﬁcient to decrease
mutS afﬁnity and avoid MMR correction (6). Thus, we
sought to determine if modiﬁed bases could also create
local distortions in the DNA structure in a manner that
reduces mutS binding and MMR-correction efﬁciency
for nearby mismatches. Modiﬁed bases 20-Fluoro-
deoxyUridine (2fU) and 5-Methyl-deoxyCytidine (5mC)
were chosen because they showed the highest MMR
evasion phenotype. Oligos containing easily corrected
G:G, G:T, C:A and C:T mismatches within 1–5bp from
a correctly paired modiﬁed base were used for allelic re-
placement in mutS(+) EcNR1 and mutS( ) EcNR2
(Figure 3a). We found that in EcNR1, mismatch C:T
could be much more efﬁciently incorporated when a 2fU
base was located in close proximity (Figure 3b). However,
this improved allelic-replacement efﬁciency was not seen
with other mismatch pairs, suggesting that such a strategy
might be dependent on sequence context. We have previ-
ously observed similar sequence context effects on the
allelic-replacement efﬁciency at the target site due to in-
hibitory hairpin secondary structures of the oligo (9). An
oligo folding energy of less than  12.5kcal/mol signiﬁ-
cantly decreased the AR efﬁciency and should be
avoided by redesigning the oligo homology arms with
less hairpin structure. The 5mC base did not improve
the efﬁciency of incorporation of any nearby mismatches,
suggesting that the modiﬁed base did not create sufﬁcient
DNA structural distortion to affect MMR correction.
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mutS( ). Labeled black bars correspond to correction efﬁciency in oligos with modiﬁed bases, showing a drastic decrease compared with standard
bases, (G:T with F-U, T:C with 5MeC, C:A with DiPr, G:G with Iso-G). See Table 2 for a list of oligos used. Error bars are standard errors with
n=6–15. (d) Chemical structures of the best-performing modiﬁed bases.
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in EcNR2 indicating that the nearby modiﬁed bases did
not affect replication ﬁdelity (Figure 3c).
Local processing of the oligonucleotide during
allelic replacement
While mismatches can be effectively introduced through
MMR evasion, the overall efﬁciency of allelic replacement
is determined by the oligo processing at the replication
fork. Previously, we and others have generally observed
that mismatches located at the 30 or 50 terminus of the
oligo could not be incorporated into the chromosome
through allelic replacement (11) or double-stranded
DNA recombineering (13). However, a more recent
study has suggested that a single base pair mismatch
located at the oligo termini could be incorporated, but
at very low efﬁciency (<0.01%) (42). To further elucidate
the basis of these observations, we performed a detailed
investigation of how oligonucleotides are processed at the
site of allelic replacement. To this end, we performed
allelic replacement using a 90bp oligo (lacZm4v1) that
contained six single-nucleotide polymorphisms in the
coding region, resulting in six non-consecutive amber
stop codons. Incorporation of any of the six mutations
on the single oligo would inactivate the lacZ gene, the
function of which was assayed for in the DmutS EcNR2
strain. The oligos were introduced by allelic replacement
to produce white colonies at an efﬁciency of  10%. We
isolated 47 white lacZ mutants and sequenced the lacZ
region targeted by the oligo (Figure 4a). Surprisingly,
only 34% of the isolates contained all six amber stop
mutations. More than 53% of isolates had four or ﬁve
mutations while the rest had one to three mutations. In
general, the mutations were grouped consecutively, where
only the 50 or 30 terminal mutations were not incorporated.
In rare instances, we observed incorporation of the two 50
and 30 terminal mutations, but not mutations in the
middle of the oligo (e.g. isolates 5, 13 and 14). We specu-
late that these anomalies correspond to rare events in
which two independent allelic-replacement events
occurred sequentially, where the ﬁrst led to incomplete
incorporation at one terminus and the second led to in-
complete incorporation at the other terminus. The middle
sequences were therefore left unchanged. These putative
multiple replacement events occur for  6% of isolates
that have undergone allelic replacement.
The pattern of incomplete incorporation of the full
length oligo was observed across different target sequences
and at different loci (i.e. lacZ, galK). For oligos that do
undergo allelic replacement, mutations nearest to the
termini are the least frequently incorporated (Figure 4b).
Only 7% of clones incorporated mismatches 6bp from the
30 terminus, and 52% of oligos incorporated mismatches
9bp from the 50 terminus. In contrast, mutations at
the center of the 90bp oligo were incorporated 97%
of the time. Previously, we showed that oligos with
terminal phosphorothioated (PT) bases had increased
allelic-replacement efﬁciency, presumably due to the pre-
vention of ssDNA-nuclease activity (9). Thus, we sought
to use protective PT bases at the termini in order to de-
termine whether the observed incomplete oligo incorpor-
ation was due to oligo truncation from cytosolic nuclease
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Figure 3. (a) Diagram for mismatch repair avoidance using proximal modiﬁed bases that can prevent MutS recognition and activation of the
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that oligos containing four PT bases at the 50 terminus had
the same incomplete incorporation pattern as oligos
without PT bases or oligos with four PT bases at the
center of the oligo, leading us to hypothesize that this
oligo processing mechanism may be acting more generally
at the replication fork by speciﬁc endonucleases. We
found that oligo truncation also occurred for leading
strand targeting oligos, despite these oligos having
>10-fold lower allelic-replacement efﬁciency (data not
shown). Oligo processing appears to be RecA-
independent, as oligo truncation was also found using
the DrecA strain EcZS2.
We then performed allelic-replacement experiments in
which three oligo variants (lacZm6_A, lacZm6_T and
lacZm6_G) that exclusively introduced non-consecutive
G:G, G:T or G:A mismatches were simultaneously
co-electroporated into cells for allelic replacement to
screen for mutants. In this multiplexed reaction, we antici-
pate that the three oligo variants would incorporate com-
petitively into the chromosome. In the DmutS EcNR2
strain, we found that of 93 white clones screened and
sequenced, all three variants (G:G, G:T and G:A) were
represented equally, with similar oligo truncation
patterns seen previously (Figure 5a). However, using
galK oligo variants (galKm1_A, galKm1_T and
galKm1_G) in the mutS(+) EcNR1 strain, we found that
94% of the isolated strains were the G:A variant, 5% were
G:T, and 1% were G:G (Figure 5b). The under-
representation of G:G and G:T variants demonstrated
that the MMR system in EcNR1 could very efﬁciently
correct multiple mismatches. We also observed a
stronger oligo truncation pattern at the 30 terminus in
the mutS(+) EcNR1 strain in comparison to the DmutS
EcNR2 strain (Figure 5c). Mismatches encoded on the
90bp oligo at positions 66–70 were found in only 43%
of mutants of mutS(+) EcNR1 in comparison to 84% of
mutants of DmutS EcNR2. We speculate that the
oligo-derived mismatches here are being processed in the
30 to 50 direction to produce the 30 truncation pattern.
DISCUSSION
Oligo-mediated allele-replacement techniques can now
reach efﬁciencies of up to 20–30%, with iterable cycles
capable of being performed every 2–3h (9). This high
allelic-replacement efﬁciency relied on the removal of the
native mismatch repair system through knockout of
components of the MutHLS complex. However, the
background mutation rate is 100 times higher in such
MMR-deﬁcient strains, which presents an undesirable
limitation for high accuracy genome engineering.
Recently, Sawitzke et al. (11) showed that oligos with
multiple C:C mismatches making silent mutations can
effectively avoid MutS recognition. Here, we presented
an alternative strategy that uses oligonucleotides contain-
ing modiﬁed bases 20-Fluoro-deoxyUridine, 5-Methyl-
deoxyCytidine, 2,6-Diaminopurine or Iso-deoxy
Guanosine to effectively evade MMR to improve allelic-
replacement efﬁciency in a strain with native MMR
activity. This strategy may be generally useful to
improve and expand the capabilities of OMAR in other
organisms. Strategies that increase the efﬁciency of allelic
replacement while maintaining genomic stability will be
essential for high-precision genome engineering. We an-
ticipate that there are other modiﬁed nucleotide bases
that can both be well-processed by the DNA replication
machinery and destabilize the mismatch lesion to prevent
MMR activity at the targeted site. Practical considerations
for researchers using oligos with modiﬁed bases may
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sis. While we have not observed any negative effects on
viability of E. coli cells transformed with the modiﬁed
bases tested here, a more detailed cell viability study
using these modiﬁed bases are needed, especially for eu-
karyotic organisms. Additional investigations are needed
to determine how modiﬁed bases perform among other
organisms with different MMR systems.
Previously, Costantino and Court (29) had shown that
using the  -Red system in E. coli, the efﬁciency of target-
ing is 30-fold higher with the oligo that corresponds to the
lagging strand in comparison to oligos that correspond to
the leading strand (1). Since oligos targeting the leading
strand is much less efﬁciently incorporated into the
chromosome even in mismatch repair deﬁcient strains
(i.e. DmutS), the use of modiﬁed bases to avoid
mismatch repair in these leading strand targeted oligos is
not a practical route for making genomic changes.
Instead, we recommend using lagging strand targeting
ODNs with modiﬁed bases as a much more efﬁcient
approach for genome engineering.
When examining the local processing of the oligo at the
target site, we found that the full-length 90bp oligo was
often not incorporated in its entirety. The center of the
oligo was incorporated most frequently, with incorpor-
ation frequency decreasing toward the two termini.
The 30 and 50 terminal bases were never observed to
undergo any allelic replacement in our experiments.
Exonuclease activity in both directions may account for
these observations. Interestingly, we noted that tandem
terminal 50 phosphorothioated bases, which increase the
overall efﬁciency of oligo incorporation, did not affect the
frequency at which the incomplete 50 incorporation was
observed. Protection of the mismatching bases with
phosphorothioated bases also showed no effect in prevent-
ing incomplete incorporation. Furthermore, oligos that
targeted the leading strand also produced similar 50 and
30 truncations of the oligo. These observations suggest that
phosphorothioated bases are effective at reducing oligo
degradation by cytosolic exonucleases, but do not affect
processing of the oligo at the replication fork.
The results of this work provide a general guideline
for the efﬁcient design of oligonucleotides for allelic-
replacement strategies such as MAGE. To design
mismatch mutations on the 90-mer oligo, we suggest
placement of mutations at the center of the oligonucleo-
tide to prevent terminal truncations from interfering with
the targeted allelic replacement. We speculate that
removal of endogenous nucleases may reduce oligo trun-
cation, but might simultaneously result in other pheno-
types such as decreased ﬁtness. The oligo chew-back
phenomenon observed here may be beneﬁcial in certain
applications. For example, in protein mutagenesis or
sequence diversity generation using allelic replacement, a
single oligo can be used to generate a heterogeneous popu-
lation of cells containing multiple truncated forms of the
full target oligo to produce combinatorial variants.
Oligo-mediated genetic exchange has been documented
in many other organisms including Gram-positive
bacteria, yeast and mammalian cells (15,21,43).
Improvements to the efﬁciency and predictability of
oligo incorporation by avoiding native repair systems
and overcoming nuclease degradation should be general-
izable to these other organisms. Such efforts will help
further develop OMAR as a general method for protein
engineering, pathway optimization and strain manufac-
turing relevant to academic and industrial research.
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